Matches in Wikidata for { <http://www.wikidata.org/entity/Q91466668> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91466668 description "article scientifique publié en 2019" @default.
- Q91466668 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91466668 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91466668 description "scientific article published on 26 November 2019" @default.
- Q91466668 description "wetenschappelijk artikel" @default.
- Q91466668 description "наукова стаття, опублікована 26 листопада 2019" @default.
- Q91466668 name "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 name "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 type Item @default.
- Q91466668 label "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 label "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 prefLabel "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 prefLabel "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 P1433 Q91466668-820ED631-774C-43FF-BC8C-A403C10306E1 @default.
- Q91466668 P1476 Q91466668-E62D4AC2-7DC3-44D0-96BC-1C4DD0AC1FE7 @default.
- Q91466668 P2093 Q91466668-20728D7D-A596-4424-8215-4DFDF5362954 @default.
- Q91466668 P2093 Q91466668-50E35713-23B6-4AE1-9271-3F8545E2C6A7 @default.
- Q91466668 P2093 Q91466668-97F2018B-040D-4DB2-AB31-16CCF993D7B9 @default.
- Q91466668 P2093 Q91466668-AE381ED0-6C0A-4B7E-8DD6-A3EFAD2CE818 @default.
- Q91466668 P31 Q91466668-BC23A21F-5D1C-4CFF-BCC0-AAD4B332B774 @default.
- Q91466668 P356 Q91466668-5091ADA0-722E-4ECB-BA0B-28539710664C @default.
- Q91466668 P577 Q91466668-8980E7A3-83FC-47D3-A7C4-283F69A37A47 @default.
- Q91466668 P698 Q91466668-08CB28CA-C471-4C46-B875-0B016ED072F6 @default.
- Q91466668 P921 Q91466668-29E86249-F532-4B6C-84DB-DC1517F30A53 @default.
- Q91466668 P921 Q91466668-45090177-2077-441A-B44C-392AEADA7CDA @default.
- Q91466668 P921 Q91466668-65BDD619-0DF4-464B-B88B-996C57283310 @default.
- Q91466668 P356 A-1012-1999 @default.
- Q91466668 P698 31770787 @default.
- Q91466668 P1433 Q15767651 @default.
- Q91466668 P1476 "[Fluorescence Angiography-assisted Management of Recurrences in Aggressive Posterior Retinopathy of Prematurity (APROP) after Intravitreal Monotherapy with 0.312 mg Bevacizumab]" @default.
- Q91466668 P2093 "Birgit Lorenz" @default.
- Q91466668 P2093 "Christine Mais" @default.
- Q91466668 P2093 "Knut Stieger" @default.
- Q91466668 P2093 "Monika Andrassi-Darida" @default.
- Q91466668 P31 Q13442814 @default.
- Q91466668 P356 "10.1055/A-1012-1999" @default.
- Q91466668 P577 "2019-11-26T00:00:00Z" @default.
- Q91466668 P698 "31770787" @default.
- Q91466668 P921 Q1423087 @default.
- Q91466668 P921 Q413299 @default.
- Q91466668 P921 Q468414 @default.